Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1980 2
1981 1
1982 1
1985 3
1986 4
1987 5
1988 3
1989 2
1990 4
1991 2
1992 3
1993 2
1994 2
1995 2
1997 1
1998 1
1999 2
2000 2
2001 3
2002 3
2003 2
2004 4
2005 9
2006 12
2007 10
2008 10
2009 6
2010 12
2011 17
2012 15
2013 8
2014 5
2015 6
2016 4
2017 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

156 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Rüschoff J, Kang YK; ToGA Trial Investigators. Bang YJ, et al. Lancet. 2010 Aug 28;376(9742):687-97. doi: 10.1016/S0140-6736(10)61121-X. Epub 2010 Aug 19. Lancet. 2010. PMID: 20728210 Clinical Trial.
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Grothey A, Van Cutsem E, Sobrero A, Siena S, Falcone A, Ychou M, Humblet Y, Bouché O, Mineur L, Barone C, Adenis A, Tabernero J, Yoshino T, Lenz HJ, Goldberg RM, Sargent DJ, Cihon F, Cupit L, Wagner A, Laurent D; CORRECT Study Group. Grothey A, et al. Lancet. 2013 Jan 26;381(9863):303-12. doi: 10.1016/S0140-6736(12)61900-X. Epub 2012 Nov 22. Lancet. 2013. PMID: 23177514 Clinical Trial.
[Cetuximab].
Takiuchi H. Takiuchi H. Gan To Kagaku Ryoho. 2007 Aug;34(8):1192-5. Gan To Kagaku Ryoho. 2007. PMID: 17687200 Review. Japanese.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki K, Clingan PR, Lonardi S, Kim TW, Simms L, Chang SC, Nasroulah F; RAISE Study Investigators. Tabernero J, et al. Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12. Lancet Oncol. 2015. PMID: 25877855 Clinical Trial.
Retroperitoneal schwannoma.
Takatera H, Takiuchi H, Namiki M, Takaha M, Ohnishi S, Sonoda T. Takatera H, et al. Among authors: takiuchi h. Urology. 1986 Dec;28(6):529-31. doi: 10.1016/0090-4295(86)90161-5. Urology. 1986. PMID: 3787928
[Second-line chemotherapy in gastric cancer].
Takiuchi H, Goto M, Kawabe S, Ohta S, Katsu K. Takiuchi H, et al. Gan To Kagaku Ryoho. 2005 Jan;32(1):19-23. Gan To Kagaku Ryoho. 2005. PMID: 15675576 Review. Japanese.
Long-Term Results of Obturator Bypass.
Masaki H, Tabuchi A, Yunoki Y, Kuwata N, Tamura T, Honda T, Takiuchi H, Yamasawa T, Furukawa H, Kuinose M, Tanemoto K, Watanabe Y. Masaki H, et al. Among authors: takiuchi h. Ann Vasc Dis. 2016;9(2):80-4. doi: 10.3400/avd.oa.15-00085. Epub 2016 Mar 11. Ann Vasc Dis. 2016. PMID: 27375799 Free PMC article.
156 results